Lewis Score on Capsule Endoscopy as a Predictor of the Risk for Crohn’s Disease-Related Emergency Hospitalization and Clinical Relapse in Patients with Small Bowel Crohn’s Disease

Abstract EN

Background.

Small bowel capsule endoscopy (CE) is a useful tool for evaluating the mucosal changes in patients with Crohn’s disease (CD).

The Lewis score (LS) on CE could be used to objectively assess the inflammatory activity of the small bowel mucosa.

However, only few reports on the correlation between the LS and CD prognosis exist.

This study is aimed at evaluating the clinical significance of the LS by determining the cutoff value of the LS that could predict CD-related emergency hospitalization.

Methods.

This retrospective single-center study included 125 patients who underwent CE for small bowel CD.

Eighty-six patients whose treatment was not changed after CE were analyzed.

Inflammatory activity was assessed with the LS.

We examined the clinical course of the patients who could be observed for 1 year after CE and investigated the LS cutoff value that could predict CD-related emergency hospitalization within 1 year.

We also examined the hospitalization-free and clinical relapse-free rates using the LS cutoff value and evaluated the factors related to emergency hospitalization.

Results.

The LS cutoff value that could predict CD-related emergency hospitalization within 1 year was 264 (area under the curve, 0.92 (P<0.001); sensitivity, 0.80; and specificity, 0.94).

The cumulative hospitalization-free rate and cumulative clinical relapse-free rate were significantly higher in patients with a LS<264 (P<0.001).

Multivariate analysis showed that a LS<264 was a statistically significant factor (P=0.001; 95% CI, 0.010–0.308).

Conclusion.

A LS of 264 is a useful cutoff value that could predict CD-related emergency hospitalization.

This LS cutoff value may help determine treatment strategies for CD.